GSDMA and neoplasm: Although researchers have attempted to increase GSDM protein expression in tumor cells via the small‐molecule drug decitabine or gene editing methods, the effectiveness and safety of these approaches still require improvement.[21a] Decitabine, when used to upregulate GSDM protein expression in tumor cells, has low upregulation efficacy and poor targeting ability, which can trigger systemic inflammatory responses.